Rate My Professor Anjelica Gonzalez

Her research specializes in the development of biomimetic materials and engineered scaffolds to investigate immunological responses to inflammatory signals, focusing on the chemo-mechanics of processes in microvascular structures. The Gonzalez Lab integrates organic chemistry, molecular biology, mathematics, computational modeling, and image analysis to study diseases such as vascular inflammation, stroke, fibrosis, sepsis, atherosclerosis, arthritis, diabetes, and cutaneous T-cell lymphoma. Collaborations with Yale School of Medicine departments explore dermal and pulmonary fibrosis mechanisms. Translational work includes PremieBreathe, a low-cost, mobile neonatal respiratory device supported by USAID, Bill & Melinda Gates Foundation, and NCIIA/Venturewell for deployment in low-infrastructure settings like Ethiopia. Key publications include "Minimally Invasive Delivery of Microbeads with Encapsulated, Viable and Quiescent Neural Stem Cells to the Adult Subventricular Zone" (Scientific Reports, 2019), "An endothelial microRNA-1 regulated network controls eosinophil trafficking in asthma and chronic rhinosinusitis" (Journal of Allergy and Clinical Immunology, 2019), "Human pericytes adopt myofibroblast properties in the microenvironment of the IPF lung" (JCI Insight, 2017), "Mechanosensing regulates tissue repair program in macrophages" (Science Advances, 2024), and "Engineered microvascular basement membrane mimetic for real-time neutrophil tracking in the microvascular wall" (Bioengineering & Translational Medicine, 2025). Gonzalez has received the AIMBE College of Fellows election (2020), Biomedical Engineering Society Diversity Award (2018), Yale Provost’s Teaching Prize (2014), Hartwell Foundation Individual Biomedical Research Award (2012), and numerous fellowships including NIH LRP Awards.